Submission Details

Molecule(s):
N#Cc1ccc(CNC(=O)N2CCOCC2)c(CN2CCN(C(=O)CCl)CC2)c1

TAM-UNI-d1c3dd9f-1
Duplicate of:
DAR-DIA-fb20be43-16

N#Cc1ccc(CNC(=O)N2CCOCC2)c(CN2CCN(C(=O)CCl)CC2)c1

Duplicate piperazine-chloroacetamide Ordered Check Availability on Manifold View
Cn1cc(N2CCCC2C(N)=O)c(CN2CCN(C(=O)CCl)CC2)n1

TAM-UNI-d1c3dd9f-2

Cn1cc(N2CCCC2C(N)=O)c(CN2CCN(C(=O)CCl)CC2)n1

piperazine-chloroacetamide Check Availability on Manifold View
NS(=O)(=O)c1ccc2ccc(C3CN(C(=O)CCl)Cc4ccccc43)cc2c1

TAM-UNI-d1c3dd9f-3
Duplicate of:
NIR-THE-c331be7a-5

NS(=O)(=O)c1ccc2ccc(C3CN(C(=O)CCl)Cc4ccccc43)cc2c1

CN(C)C(=O)c1ccc(CNS(C)(=O)=O)c(CN2CCN(C(=O)CCl)CC2)c1

TAM-UNI-d1c3dd9f-4

CN(C)C(=O)c1ccc(CNS(C)(=O)=O)c(CN2CCN(C(=O)CCl)CC2)c1

piperazine-chloroacetamide Check Availability on Manifold View
CS(=O)(=O)N1CCc2ccc(CN3CCN(C(=O)CCl)CC3)cc2C1

TAM-UNI-d1c3dd9f-5

CS(=O)(=O)N1CCc2ccc(CN3CCN(C(=O)CCl)CC3)cc2C1

piperazine-chloroacetamide Assayed Check Availability on Manifold View
CNS(=O)(=O)c1ccc2ccc(CN3CCN(C(=O)CCl)CC3)cc2c1

TAM-UNI-d1c3dd9f-6

CNS(=O)(=O)c1ccc2ccc(CN3CCN(C(=O)CCl)CC3)cc2c1

piperazine-chloroacetamide Ordered Check Availability on Manifold View
O=C(CCl)N1Cc2ccccc2C(c2cccc(CNC(=O)N3CCOCC3)c2)C1

TAM-UNI-d1c3dd9f-7

O=C(CCl)N1Cc2ccccc2C(c2cccc(CNC(=O)N3CCOCC3)c2)C1

CS(=O)(=O)N1CCc2ccc(C3CN(C(=O)CCl)Cc4ccccc43)cc2C1

TAM-UNI-d1c3dd9f-8

CS(=O)(=O)N1CCc2ccc(C3CN(C(=O)CCl)Cc4ccccc43)cc2C1

NC(=O)C1CCCN1c1ccccc1CN1CCN(C(=O)CCl)CC1

TAM-UNI-d1c3dd9f-9
Duplicate of:
DUN-NEW-f8ce3686-2

NC(=O)C1CCCN1c1ccccc1CN1CCN(C(=O)CCl)CC1

Duplicate piperazine-chloroacetamide Check Availability on Manifold View
CNS(=O)(=O)c1ccc(C#N)c(C2CN(C(=O)CCl)Cc3ccccc32)c1

TAM-UNI-d1c3dd9f-10

CNS(=O)(=O)c1ccc(C#N)c(C2CN(C(=O)CCl)Cc3ccccc32)c1

CC(=O)NCCCc1cn(C)c2cc(C3CN(C(=O)CCl)Cc4ccccc43)ccc12

TAM-UNI-d1c3dd9f-11

CC(=O)NCCCc1cn(C)c2cc(C3CN(C(=O)CCl)Cc4ccccc43)ccc12

O=C(CCl)N1CCN(Cc2cccc(CNC(=O)N3CCOCC3)c2)CC1

TAM-UNI-d1c3dd9f-12

O=C(CCl)N1CCN(Cc2cccc(CNC(=O)N3CCOCC3)c2)CC1

piperazine-chloroacetamide Assayed Check Availability on Manifold View
CC(=O)N1CCCc2cccc(CN3CCN(C(=O)CCl)CC3)c2C1

TAM-UNI-d1c3dd9f-13

CC(=O)N1CCCc2cccc(CN3CCN(C(=O)CCl)CC3)c2C1

piperazine-chloroacetamide Ordered Check Availability on Manifold View
O=C1Cc2c(cccc2CN2CCN(C(=O)CCl)CC2)CCN1

TAM-UNI-d1c3dd9f-14

O=C1Cc2c(cccc2CN2CCN(C(=O)CCl)CC2)CCN1

piperazine-chloroacetamide Ordered Check Availability on Manifold View
O=C1NCCCc2cccc(CN3CCN(C(=O)CCl)CC3)c21

TAM-UNI-d1c3dd9f-15

O=C1NCCCc2cccc(CN3CCN(C(=O)CCl)CC3)c21

piperazine-chloroacetamide Check Availability on Manifold View
CC(=O)Nc1cc(C#N)cc(CN2CCN(C(=O)CCl)CC2)c1

TAM-UNI-d1c3dd9f-16

CC(=O)Nc1cc(C#N)cc(CN2CCN(C(=O)CCl)CC2)c1

piperazine-chloroacetamide Check Availability on Manifold View
CNC(=O)c1ccc(C#N)cc1CN1CCN(C(=O)CCl)CC1

TAM-UNI-d1c3dd9f-17

CNC(=O)c1ccc(C#N)cc1CN1CCN(C(=O)CCl)CC1

piperazine-chloroacetamide Ordered Check Availability on Manifold View
CC(=O)Nc1ccc(C#N)cc1CN1CCN(C(=O)CCl)CC1

TAM-UNI-d1c3dd9f-18

CC(=O)Nc1ccc(C#N)cc1CN1CCN(C(=O)CCl)CC1

piperazine-chloroacetamide Assayed Check Availability on Manifold View
CC(=O)NCCc1cn(C)c2cc(CN3CCN(C(=O)CCl)CC3)ccc12

TAM-UNI-d1c3dd9f-19

CC(=O)NCCc1cn(C)c2cc(CN3CCN(C(=O)CCl)CC3)ccc12

piperazine-chloroacetamide Check Availability on Manifold View
CC(=O)NCCc1cn(C)c2c(CN3CCN(C(=O)CCl)CC3)cccc12

TAM-UNI-d1c3dd9f-20

CC(=O)NCCc1cn(C)c2c(CN3CCN(C(=O)CCl)CC3)cccc12

piperazine-chloroacetamide Check Availability on Manifold View
CC(NC(=O)CCl)c1ccccc1CNC(=O)N1CCOCC1

TAM-UNI-d1c3dd9f-21

CC(NC(=O)CCl)c1ccccc1CNC(=O)N1CCOCC1

CC(NC(=O)CCl)c1ccc2ccc(NS(C)(=O)=O)cc2c1

TAM-UNI-d1c3dd9f-22

CC(NC(=O)CCl)c1ccc2ccc(NS(C)(=O)=O)cc2c1

CC(=O)NCCc1cn(C)c2cc(C(C)NC(=O)CCl)ccc12

TAM-UNI-d1c3dd9f-23

CC(=O)NCCc1cn(C)c2cc(C(C)NC(=O)CCl)ccc12

CC(=O)NCCc1cn(C)c2c(C(C)NC(=O)CCl)cccc12

TAM-UNI-d1c3dd9f-24

CC(=O)NCCc1cn(C)c2c(C(C)NC(=O)CCl)cccc12


Design Rationale:

Covalent fragments were re-docked using multiple protein conformations. Docking results were ranked based on the overlapping of the structures with the original X-rays. Selected fragments were superimposed with the non-covalent hits and the designed structures (only chloroacetamides at this stage) were re-docked and ranked based on their overlapping with the X-ray fragments. x0104, x0195, x1249, x0305, x0946, x0161, x0847

Inspired By:
Discussion: